{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=tolterodine", "query": { "intervention": "tolterodine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 48, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=tolterodine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-09T02:09:52.889Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00909181", "title": "Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urge Urinary Incontinence", "Urinary Frequency" ], "interventions": [ { "name": "Oxybutynin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Antares Pharma Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 626, "start_date": "2009-03", "completion_date": "2010-11", "has_results": true, "last_update_posted_date": "2014-07-02", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 55, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • Laguna Hills, California + 50 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Laguna Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00909181" }, { "nct_id": "NCT07780786", "title": "Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overactive Bladder (OAB)" ], "interventions": [ { "name": "Wearable neurostimulation system for saphenous nerve stimulation", "type": "DEVICE" }, { "name": "tolterodine tartrate 4 mg extended release", "type": "DRUG" } ], "intervention_types": [ "DEVICE", "DRUG" ], "sponsor": "NinaMED Pty Ltd", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 290, "start_date": "2026-09-10", "completion_date": "2028-01-30", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 1, "location_summary": "Camden, New Jersey", "locations": [ { "city": "Camden", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT07780786" }, { "nct_id": "NCT01302054", "title": "A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Urinary Bladder, Overactive" ], "interventions": [ { "name": "Fesoterodine 8 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 990, "start_date": "2011-05", "completion_date": "2012-05", "has_results": true, "last_update_posted_date": "2018-12-04", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 109, "location_summary": "Birmingham, Alabama • Fairhope, Alabama • Chandler, Arizona + 80 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Green Valley", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01302054" }, { "nct_id": "NCT00649727", "title": "Fed Study of Oxybutynin Chloride Extended-release Tablets 10 mg and Ditropan XL® Tablets 10 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Oxybutynin Chloride ER Tablets 10 mg", "type": "DRUG" }, { "name": "Ditropan XL® Tablets 10 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 24, "start_date": "2002-07", "completion_date": "2002-08", "has_results": false, "last_update_posted_date": "2024-04-23", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00649727" }, { "nct_id": "NCT00611026", "title": "Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Overactive Bladder" ], "interventions": [ { "name": "Tolterodine ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fesoterodine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2417, "start_date": "2008-02", "completion_date": "2009-10", "has_results": true, "last_update_posted_date": "2011-02-02", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 102, "location_summary": "Enterprise, Alabama • Mobile, Alabama • Montgomery, Alabama + 85 more", "locations": [ { "city": "Enterprise", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00611026" }, { "nct_id": "NCT00649259", "title": "Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Oxybutynin Chloride ER Tablets 10 mg", "type": "DRUG" }, { "name": "Ditropan XL® Tablets 10 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mylan Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 39, "start_date": "2002-10", "completion_date": "2002-11", "has_results": false, "last_update_posted_date": "2024-04-24", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 1, "location_summary": "Morgantown, West Virginia", "locations": [ { "city": "Morgantown", "state": "West Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00649259" }, { "nct_id": "NCT05658874", "title": "A Multidisciplinary, Multimodal Bundled Care Approach to Chronic Pelvic Pain", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Interstitial Cystitis", "Levator Spasm", "Bladder Pain Syndrome" ], "interventions": [ { "name": "Multimodal Bundle Drugs", "type": "DRUG" }, { "name": "Operative Cystoscopy", "type": "PROCEDURE" }, { "name": "Behavioral health consultation/therapy", "type": "BEHAVIORAL" }, { "name": "Pelvic floor physical therapy", "type": "OTHER" }, { "name": "Usual Urogynecologic care", "type": "OTHER" }, { "name": "Bladder Instillation", "type": "DRUG" }, { "name": "Vaginal estrogen", "type": "DRUG" }, { "name": "Methenamine", "type": "DRUG" }, { "name": "Amitriptyline/Gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG", "PROCEDURE", "BEHAVIORAL", "OTHER" ], "sponsor": "Jocelyn Fitzgerald", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "FEMALE", "summary": "18 Years to 99 Years · Female only" }, "enrollment_count": 26, "start_date": "2022-12-06", "completion_date": "2025-12-30", "has_results": true, "last_update_posted_date": "2026-04-01", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT05658874" }, { "nct_id": "NCT00703703", "title": "Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Darifenacin", "type": "DRUG" }, { "name": "Tolterodine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 117, "start_date": "2008-05", "completion_date": "2008-10", "has_results": false, "last_update_posted_date": "2012-08-02", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 21, "location_summary": "Phoenix, Arizona • Tempe, Arizona • Little Rock, Arkansas + 18 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Diego", "state": "California" }, { "city": "Washington D.C.", "state": "District of Columbia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00703703" }, { "nct_id": "NCT01741454", "title": "Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ureteral Obstruction" ], "interventions": [ { "name": "Tamsulosin", "type": "DRUG" }, { "name": "Tolterodine ER", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 181, "start_date": "2012-11", "completion_date": "2018-03-30", "has_results": true, "last_update_posted_date": "2019-07-10", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01741454" }, { "nct_id": "NCT02386072", "title": "A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Urinary Bladder Overactive", "Overactive Bladder", "Urinary Bladder Diseases", "Urologic Diseases" ], "interventions": [ { "name": "mirabegron", "type": "DRUG" }, { "name": "antimuscarinic medication", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Scientific & Medical Affairs, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1524, "start_date": "2015-01-05", "completion_date": "2017-08-04", "has_results": false, "last_update_posted_date": "2024-10-16", "last_synced_at": "2026-09-09T02:09:52.889Z", "location_count": 75, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Mobile, Alabama + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02386072" } ] }